Showing results (91-100 of 181) with videos related to

Sort By:
Pageof 19
Molecular Cancer Research : MCR|March 4, 2008
MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancersAnn Forslund, Zhaoshi Zeng, Li-Xuan Qin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's EsophagusXiaohong Li, Thomas G Paulson, Patricia C Galipeau, et al.
Annals of Surgery|July 9, 2019
Histologic Subtype Defines the Risk and Kinetics of Recurrence and Death for Primary Extremity/Truncal LiposarcomaEdmund K Bartlett, Christina E Curtin, Kenneth Seier, et al.
Plos Pathogens|July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
Gynecologic Oncology|March 1, 2011
A microRNA survival signature (MiSS) for advanced ovarian cancerKarin K Shih, Li-Xuan Qin, Edward J Tanner, et al.
Breast Cancer Research and Treatment|November 15, 2011
Cadherin-catenin complex dissociation in lobular neoplasia of the breastMary Morrogh, Victor P Andrade, Dilip Giri, et al.
Annals of Surgery|April 28, 2015
Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal SarcomaMarcus C B Tan, Murray F Brennan, Deborah Kuk, et al.
JCO Precision Oncology|September 24, 2025
Histologic Subvariants of Retroperitoneal Well-Differentiated Liposarcoma Show Evidence of Clinical and Genomic Progression Toward Dedifferentiated LiposarcomaGeorge Z Li, Jay Lee, Karissa Whiting, et al.
The Journal of Surgical Research|July 23, 2011
Differentially expressed genes in window trials are influenced by the wound-healing process: lessons learned from a pilot study with anastrozoleMary Morrogh, Victor P Andrade, Asawari J Patil, et al.
The Journal of Infectious Diseases|February 3, 2005
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trialPeter B Gilbert, Michael L Peterson, Dean Follmann, et al.
Pageof 19